Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    Obama's State of the Union Address Was Short on Math

    The 2013 State of the Union Address was high on rhetoric... but fell short in two other areas.
    As with most Obama speeches, it was beautifully delivered. However, even where I agreed with some of the ideas, I couldn't quell a nagging suspicion that some of the numbers he was spouting simply didn't add up. And let's face it, some of the ideas in the speech were just plain bad.
    President Obama was even bold enough to claim, "Nothing I'm proposing tonight should increase our deficit by a single dime." Then he let loose with a list of new initiatives!
    Put politely, Obama's math simply doesn't add up...
    Read More...
  • president obama state of the union transcript 2012